Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Gill

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
HIV Medicine|January 12, 2019
De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savingsH B Krentz, S Campbell, M Lahl, et al.
AIDS (London, England)|December 2, 1998
Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitorA Mocroft, M J Gill, W Davidson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?A Mocroft, M J Gill, W Davidson, et al.
Archives of Dermatology|March 1, 1990
Human orf. A diagnostic consideration?M J Gill, J Arlette, K A Buchan, et al.
HIV Medicine|September 22, 2012
Predictors of symptomatic HIV-associated neurocognitive disorders in universal health careJ A McCombe, P Vivithanaporn, M J Gill, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2000
Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United KingdomS Simjee, S E Manzoor, A P Fraise, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 8, 2013
Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patientsC S Coffin, C Osiowy, R P Myers, et al.
HIV Medicine|January 26, 2018
Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savingsH B Krentz, S Campbell, V C Gill, et al.
FEMS Microbiology Letters|June 1, 1994
Naturally occurring PIA/PIB hybrids of Neisseria gonorrhoeaeM J Gill, J Jayamohan, M P Lessing, et al.
Epidemiology and Infection|September 11, 2020
The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospitalA Aryee, P Rockenschaub, M J Gill, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
HIV Medicine|January 12, 2019
De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savingsH B Krentz, S Campbell, M Lahl, et al.
AIDS (London, England)|December 2, 1998
Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitorA Mocroft, M J Gill, W Davidson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?A Mocroft, M J Gill, W Davidson, et al.
Archives of Dermatology|March 1, 1990
Human orf. A diagnostic consideration?M J Gill, J Arlette, K A Buchan, et al.
HIV Medicine|September 22, 2012
Predictors of symptomatic HIV-associated neurocognitive disorders in universal health careJ A McCombe, P Vivithanaporn, M J Gill, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2000
Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United KingdomS Simjee, S E Manzoor, A P Fraise, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 8, 2013
Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patientsC S Coffin, C Osiowy, R P Myers, et al.
HIV Medicine|January 26, 2018
Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savingsH B Krentz, S Campbell, V C Gill, et al.
FEMS Microbiology Letters|June 1, 1994
Naturally occurring PIA/PIB hybrids of Neisseria gonorrhoeaeM J Gill, J Jayamohan, M P Lessing, et al.
Epidemiology and Infection|September 11, 2020
The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospitalA Aryee, P Rockenschaub, M J Gill, et al.
Pageof 15